Aptuit Drug Discovery & Development Center In Verona, Italy Hits 100th Client Milestone

Aptuit Drug Discovery & Development Center In Verona, Italy Hits 100th Client Milestone PR Newswire GREENWICH, Connecticut, Nov. 8, 2012 GREENWICH, Connecticut, Nov. 8, 2012 /PRNewswire/ -- Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence from the marketplace. http://photos.prnewswire.com/prnh/20120217/NY55633LOGO Mark Hembarsky, Vice President and Site Leader of the facility stated, "We are excited to have reached this important milestone of 100 clients at Aptuit Verona. In July of 2010, we started with one client, GlaxoSmithKline, following our acquisition of the site from them. Since that time, more and more clients have been recognizing that we have something unique and valuable to offer, and that we are certainly doing something right in helping them achieve their goals." Mr. Hembarsky explained that in the two brief years since the acquisition, the Aptuit Verona facility has successfully made the transition from a single customer site to a dynamic drug discovery and development center attracting all types of clients – large, multinational pharmaceutical innovators, midsize and small pharma companies, biotechs and startups. "Companies from the EU, North America, Asia and South America have placed projects with us covering numerous therapeutic areas," said Mr. Hembarsky.